Navigation Links
US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Date:12/1/2011

an Aromatase Inhibitor - Wright GL, Blum JL, Krekow LK, McIntyre KJ, Wilks ST, Rabe AC, Vukelja SJ, Andersen JC, Wang Y, Asmar L, O'Shaughnessy J
  • 5:15-7:00 pm CST, Thursday, Dec. 8 (Ballroom B): Primary and secondary pegfilgrastim utilization in adjuvant chemotherapy for breast cancer in the community - Patt, DA, Espirito, JL, Turnwald, B, Hoverman JR, Neubauer MA, Busby LT, Brooks BD, Kolodziej MA, Anderson RW, Beveridge RA
  • 7:00-9:00 am CST, Friday, Dec. 9 (Ballroom A): Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) plus Trastuzumab (HER TC) in HER2-Positive Early Stage Breast Cancer Patients - Jones S, Collea R, Paul D, Oratz R, Sedlacek S, Favret A, Gore Jr. I, Lindquist D, Holmes FA, Allison MAK, Steinberg MS, Stokoe C, Portillo R, Crockett M, Wang Y, Asmar L, Robert N, O'Shaughnessy J
  • Posters:
    • 5:00-7:00 pm CST, Friday, Dec. 9 (Exhibit Halls A-B): The Incidence of Febrile Neutropenia in the First Course of Adjuvant Chemotherapy with Docetaxel/Cyclophosphamide with or without Pegfilgrastim - Jones S, Paul D, Sedlacek S, Vukelja S, Wilks S, Stokoe C, Osborne C, Krekow L, McIntyre K, Holmes FA, Zhan F, Guerra L, Asmar L, O'Shaughnessy J, Blum J
    • 5:00-7:00 pm CST, Friday, Dec. 9 (Exhibit Halls A-B): Phase II Trial of Ixabepilone plus Carboplatin in Patients with Metastatic Breast Cancer: The ECLIPSE Study - Osborne C, Challagalla JD, Fanning SR, Eisenbeis CF, Holmes FA, Monaghan GG, Neubauer MA, Rabe AC, Raja V, Robbins GJ, Taboada CA, Vukelja SJ, Wilks ST, Wang Y, Brown JA, Asmar L, O'Shaughnessy J
    • 5:00-7:00 pm CST, Friday, Dec. 9 (Exhibit Halls A-B): Correlation of Clinical and Molecular Findings with Pathologic Response to Preoperative Lapatinib and Trastuzumab, Separately or in Combination, Prior to Neoadjuvant Chemotherapy for HER2 Positive Breast Cancer - Holmes FA, Espina V, Liotta LA
      '/>"/>

    SOURCE McKesson Specialty Health
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
    2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
    3. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
    4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
    5. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
    6. First Coast Oncology to Offer Next Generation Proton Therapy
    7. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
    8. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
    9. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
    10. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
    11. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
    (Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, Inc., ... Inc. (NASDAQ: SQNM ), the leading ... for next generation noninvasive prenatal tests (NIPT). Through ... technology, called Mantis™, to advance analysis of clinically-relevant ...
    (Date:12/25/2014)... 2014 The report “Service Quality Management ... & Provider Type - Global Advancements, Worldwide Forecasts & ... in-depth analysis and forecasting of revenues. , Browse ... pages and in-depth TOC on “Service Quality Management (SQM) ...
    (Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... for cells and tissues  ("BioLife" or the "Company"), today ... Stockholders on May 4, 2015 (the "Annual Meeting"). ...
    Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
    ... (NYSE: APD ) and Alter NRG Corp. ... Development Agreement (JDA) to pursue renewable energy opportunities in ... Air Products the right to license and incorporate Alter ... renewable energy projects. Air Products will initially focus ...
    ... SAN CLEMENTE, Calif., Feb. 4 To say that ... a series of successes in 2008 that are providing ... quite be telling the whole story. This past ... the young company, as it literally expanded its presence ...
    ... Board: GOVX), an Atlanta-based, publicly traded,biopharmaceutical company developing human ... other infectious agents, today,announced that its Corporate Presentation at ... live by Thomson Reuters. The Conference will be held ... 9 and 10, 2009. , ...
    Cached Biology Technology:Air Products and Alter NRG Sign JDA on Renewable Energy Projects 2Air Products and Alter NRG Sign JDA on Renewable Energy Projects 3Air Products and Alter NRG Sign JDA on Renewable Energy Projects 4While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 2While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 3While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 4GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 2GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 3
    (Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
    (Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
    (Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
    Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
    ... A new systematic assessment of malnutrition, created by ... health care providers in diagnosis and treatment. Up ... facilities are estimated to be malnourished, according to Gordon ... Although malnutrition is widespread, confusion exists in the clinical ...
    ... discovered an Achilles heel within our cells that bacteria are ... The researchers say their findings could lead to the development ... has led to resistance. University of Manchester researchers studied ... that can cause listeriosis in humans when digested and ...
    ... Samuel M. Young, Jr., PhD, research group leader ... received his first grant from The Michael J. Fox ... enable Dr. Young and colleagues to develop a technology ... research potential treatments that target LRRK2, a Parkinson,s-related gene. ...
    Cached Biology News:Researchers unveil new assessment for diagnosing malnutrition 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 3
    ... siSolutions siRNA Custom Synthesis ... effective duplex RNA to knockdown ... 21-mers (19 RNA base pairs ... recently-published 27-mers, or other lengths ...
    Alexa Fluor 647 anti-mouse Qa-2...
    ...
    Alexa Fluor 647 anti-mouse Qa-2...
    Biology Products: